Gemcitabine and Capecitabine Combination Chemotherapy in Patients with Metastatic Breast Cancer Pretreated with Anthracyclines and/or Taxanes
Authors:
- Guangyu YaoGYGuangyu Yao
- Li CaoLCLi Cao
- Mingfeng LiuMLMingfeng Liu
- Lujia ChenLCLujia Chen
- Xiaolei HuXHXiaolei Hu
- Changsheng YeCYChangsheng Ye
- 9 February 2016
- journal article
- clinical trial
- Published by S. Karger AG in Chemotherapy
- Vol. 61 (4) , 171-178
Abstract
Background: Owing to the need for effective and tolerable new regimens for the treatment of patients with metastatic breast cancer (MBC) previously treated with anthracyclines and/or taxanes, we aimed to assess the activity and safety of the gemcitabine plus capecitabine combination chemotherapy. Methods: Sixty-four patients were enrolled. Treatment consisted of gemcitabine 1,000 mg/m2 intravenously on days 1 and 8, plus oral capecitabine at 1,250 mg/m2 twice daily on days 1-14. The primary end point was the overall response rate (ORR). Secondary objectives included the disease control rate (DCR), overall survival (OS), progression-free survival (PFS), toxicity, and predictive factors. Results: In the 64 patients, the ORR and DCR was 28.1 and 67.2%. Median OS and PFS were 23.6 and 13.4 months, respectively. Toxicities were mild and curable. Conclusion: The combination of gemcitabine and capecitabine is an effective and tolerable treatment for MBC previously treated with anthracyclines and/or taxanes.Keywords
This publication has 21 references indexed in Scilit:
- Fixed-dose capecitabine is feasible: results from a pharmacokinetic and pharmacogenetic study in metastatic breast cancerBreast Cancer Research and Treatment, 2013
- Differential Pathological Response to Preoperative Chemotherapy across Breast Cancer Intrinsic SubtypesChemotherapy, 2012
- Randomised phase II trial of gemcitabine plus vinorelbine vs gemcitabine plus cisplatin vs gemcitabine plus capecitabine in patients with pretreated metastatic breast cancerBritish Journal of Cancer, 2011
- Second-Line Combination Chemotherapy with Vinorelbine and Capecitabine in Patients with Advanced Breast Cancer Previously Treated with Anthracyclines and/or TaxanesChemotherapy, 2011
- Deconstructing the molecular portraits of breast cancerMolecular Oncology, 2010
- Gemcitabine and capecitabine in previously anthracycline-treated metastatic breast cancer: a multicenter phase II study (SOLTI 0301 trial)Annals of Oncology, 2009
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)European Journal of Cancer, 2009
- Gemcitabine plus Capecitabine Combination in Metastatic Breast Cancer Patients Previously Treated with Anthracyclines and TaxanesOncology, 2007
- Gemcitabine: monochemotherapy of breast cancerAnnals of Oncology, 2006
- Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implicationsProceedings of the National Academy of Sciences of the United States of America, 2001